Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Consulting agrmnt

Immunome Inc. (IMNM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 SIEGALL CLAY B (President and CEO) has filed a Form 4 on Immunome Inc.
Txns: Bought 169,204 shares @ $5.91, valued at $1000k
10/04/2023 4 Turner Bruce (Chief Strategy Officer) has filed a Form 4 on Immunome Inc.
Txns: Bought 42,300 shares @ $5.91, valued at $250k
10/04/2023 4 PRENDERGAST FRANKLYN G (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 60,840 shares @ $0
Granted 137,725 options to buy @ $1.35, valued at $185.9k
10/03/2023 4 RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 253,806 shares @ $5.91, valued at $1.5M
06/12/2023 4 RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 6,500 options to buy @ $4.84, valued at $31.5k
06/12/2023 4 Stoneman Sandra G. (General Counsel and CLO) has filed a Form 4 on Immunome Inc.
Txns: Granted 56,000 options to buy @ $4.84, valued at $271k
06/12/2023 4 Roche Corleen M. (CFO) has filed a Form 4 on Immunome Inc.
Txns: Granted 58,000 options to buy @ $4.84, valued at $280.7k
06/12/2023 4 ROBINSON MATTHEW K (Chief Technology Officer) has filed a Form 4 on Immunome Inc.
Txns: Granted 58,000 options to buy @ $4.84, valued at $280.7k
06/12/2023 4 Sarma Purnanand D (President and CEO) has filed a Form 4 on Immunome Inc.
Txns: Granted 166,500 options to buy @ $4.84, valued at $805.9k
06/12/2023 4 Lefenfeld Michael (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 6,500 options to buy @ $4.84, valued at $31.5k
06/12/2023 4 LAMATTINA JOHN L (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 6,500 options to buy @ $4.84, valued at $31.5k
06/12/2023 4 BARON RICHARD A (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 6,500 options to buy @ $4.84, valued at $31.5k
06/12/2023 4 PRENDERGAST FRANKLYN G (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 6,500 options to buy @ $4.84, valued at $31.5k
06/12/2023 4 WAGENHEIM PHILIP (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 6,500 options to buy @ $4.84, valued at $31.5k
06/12/2023 4 Giesing Dennis H (Chief Development Officer) has filed a Form 4 on Immunome Inc.
Txns: Granted 50,000 options to buy @ $4.84, valued at $242k
01/17/2023 4 WAGENHEIM PHILIP (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 8,750 shares @ $4, valued at $35k
01/17/2023 4 LAMATTINA JOHN L (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 15,125 shares @ $4, valued at $60.5k
01/17/2023 4 Lefenfeld Michael (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 13,875 shares @ $4, valued at $55.5k
01/17/2023 4 RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 17,500 shares @ $4, valued at $70k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 ROBINSON MATTHEW K (Chief Technology Officer) has filed a Form 4 on Immunome Inc.
Txns: Granted 35,000 options to buy @ $3.42, valued at $119.7k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Lefenfeld Michael (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 6,500 options to buy @ $2.62, valued at $17k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 BARON RICHARD A (Director) has filed a Form 4 on Immunome Inc.
Txns: Granted 6,500 options to buy @ $2.62, valued at $17k
09/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/20/2021 4 BARON RICHARD A (Director) has filed a Form 4 on Immunome Inc.
Txns: Exercised 2,343 options to buy @ $11.38, valued at $26.7k
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy